Posaconazole.
Kauffman
Carol A
CA
Malani
Anurag N
AN
Easley
Chris
C
Kirkpatrick
Peter
P
D000284:Administration, Oral; D000935:Antifungal Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy; D002177:Candidiasis / Q000188:drug therapy; D002214:Capsules; D017277:Drug Approval; D015195:Drug Design; D017850:Economics, Pharmaceutical; D015725:Fluconazole / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D017964:Itraconazole / Q000627:therapeutic use; D015394:Molecular Structure; D016032:Randomized Controlled Trials as Topic; D013535:Suspensions; D013678:Technology, Pharmaceutical / Q000191:economics / Q000639:trends; D017211:Treatment Failure; D014230:Triazoles / Q000737:chemistry / Q000191:economics* / Q000627:therapeutic use*; D014481:United States
D000935:Antifungal Agents; D002214:Capsules; D013535:Suspensions; D014230:Triazoles; D017964:Itraconazole; C101425:posaconazole; D015725:Fluconazole